161 related articles for article (PubMed ID: 17462553)
1. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
Moreira AC; Gaspar A; Serra MA; Simões J; Lopes da Cruz J; Amaral TF
J Ren Nutr; 2007 May; 17(3):205-13. PubMed ID: 17462553
[TBL] [Abstract][Full Text] [Related]
2. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
3. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
Chevalier CA; Liepa G; Murphy MD; Suneson J; Vanbeber AD; Gorman MA; Cochran C
J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
[TBL] [Abstract][Full Text] [Related]
4. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
Ewers B; Riserus U; Marckmann P
J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
[TBL] [Abstract][Full Text] [Related]
5. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
Begum R; Belury MA; Burgess JR; Peck LW
J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
[TBL] [Abstract][Full Text] [Related]
7. Dietary adherence in Hispanic patients receiving hemodialysis.
Morales López C; Burrowes JD; Gizis F; Brommage D
J Ren Nutr; 2007 Mar; 17(2):138-47. PubMed ID: 17321954
[TBL] [Abstract][Full Text] [Related]
8. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
9. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study.
Madsen T; Christensen JH; Blom M; Schmidt EB
Br J Nutr; 2003 Apr; 89(4):517-22. PubMed ID: 12654170
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.
Panichi V; Rizza GM; Taccola D; Paoletti S; Mantuano E; Migliori M; Frangioni S; Filippi C; Carpi A
Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177
[TBL] [Abstract][Full Text] [Related]
12. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.
Poulia KA; Panagiotakos DB; Tourlede E; Rezou A; Stamatiadis D; Boletis J; Zampelas A
J Ren Nutr; 2011 Nov; 21(6):479-84. PubMed ID: 21439849
[TBL] [Abstract][Full Text] [Related]
14. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
15. Effects of zinc supplementation on serum zinc and C-reactive protein concentrations in hemodialysis patients.
Rashidi AA; Salehi M; Piroozmand A; Sagheb MM
J Ren Nutr; 2009 Nov; 19(6):475-8. PubMed ID: 19541504
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels.
Sutton D; Higgins B; Stevens JM
J Ren Nutr; 2007 Sep; 17(5):329-35. PubMed ID: 17720102
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
Vernaglione L; Cristofano C; Chimienti S
J Nephrol; 2008; 21(1):99-105. PubMed ID: 18264942
[TBL] [Abstract][Full Text] [Related]
18. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients.
Bradbury BD; Critchlow CW; Weir MR; Stewart R; Krishnan M; Hakim RH
Nephrol Dial Transplant; 2009 Mar; 24(3):919-25. PubMed ID: 18840893
[TBL] [Abstract][Full Text] [Related]
19. Serum concentration of amino acids versus nutritional status in hemodialysis patients.
Małgorzewicz S; Debska-Slizień A; Rutkowski B; Lysiak-Szydłowska W
J Ren Nutr; 2008 Mar; 18(2):239-47. PubMed ID: 18267217
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]